A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab

Published:2023-11 Issue:11 Volume:9 Page:e21001
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Tatli Ozge^ORCID,Oz Yagmur,Dingiloglu Baran^ORCID,Yalcinkaya Duygu,Basturk Ezgi^ORCID,Korkmaz Melis,Akbulut Latif,Hatipoglu Derya,Kirmacoglu Cansin,Akgun Buse,Turk Kubra,Pinar Orkun,Sariyar Akbulut Berna,Atabay Zeynep,Tahir Turanli Eda,Kazan Dilek,Dinler Doganay Gizem^ORCID

Funder

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference24 articles.

1. Engineered antibody fragments and the rise of single domains;Holliger;Nat. Biotechnol.,2005

2. Therapeutic antibodies: successes, limitations and hopes for the future;Chames;Br. J. Pharmacol.,2009

3. Antibody fragments and their purification by protein L affinity chromatography;Rodrigo;Antibodies,2015

4. Protein L chromatography: a useful tool for monitoring/separating homodimers during the purification of IgG-like asymmetric bispecific antibodies;Chen;Protein Expr. Purif.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP